MedPath

Early versus late intervention for twin reversed arterial perfusion sequence: an open-label randomized controlled trial *TRAPIST*: TRAP Intervention STudy

Recruiting
Conditions
TRAP acardiacus / alive fetus with no heart - TRAP pump twin/ twin giving blood to demised co twin
10016849
Registration Number
NL-OMON43488
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

MCDA twin pregnancy
Complicated by TRAP sequency diagnosed between 11+6 and 13+6 weeks AD
Anatomically normal pump twin
Age > 18
Informed consent

Exclusion Criteria

Contraindication for an intervention due to a severe maternal medical condition or threatening miscarriage
*Inaccessibility of the acardiac twin due to a retroverted uterus, severe maternal obesity, uterine fibroids, bowel or placental superposition
*A major anomaly in the pump twin, requiring surgery or leading to infant death or severe handicap
*Spontaneous arrest of the reverse flow and/or pump twin demise at diagnosis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Pump twin neonatal survival and birth at or after 34.0 weeks. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Need for re-intervention, maternal morbidity, gestational age at birth,<br /><br>neonatal outcome, 2-year neurodevelopmental outcome</p><br>
© Copyright 2025. All Rights Reserved by MedPath